ABCB1, ABCB5, ABCB8, ABCC1, ABCC2, ABCC3, and ABCG2 [22, 45–48] were considered to confer resistance to doxorubicin on the breast cancer cells. This evidence concerns the gene ABCG2 and breast cancer.